Clinical Trials Browser

Phase 2 × INDUSTRY × emibetuzumab × Clear all

NCT01900652 2019-09-18

Chime

Phase 2 Completed

111 enrolled 20 charts

Carcinoma, Non-Small-Cell Lung

NCT01874938 2015-01-16

A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer

Phase 2 Completed

Gastrointestinal

Stomach Neoplasms